Holen Sie sich die Stockscreener-App
74.78
6.58%
4.62
Vorhandelsmarkt:
78.00
3.22
+4.31%
Schlusskurs vom Vortag:
$70.16
Offen:
$70.21
24-Stunden-Volumen:
1.90M
Relative Volume:
3.78
Marktkapitalisierung:
$2.86B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-241.60M
KGV:
-11.30
EPS:
-6.6167
Netto-Cashflow:
$-201.34M
1W Leistung:
+5.64%
1M Leistung:
+9.78%
6M Leistung:
-6.91%
1J Leistung:
+38.15%
1-Tages-Spanne:
$69.44
$75.00
1-Wochen-Bereich:
$69.44
$75.00
52-Wochen-Spanne:
$40.00
$99.50
Disc Medicine Inc Stock (IRON) Company Profile
Firmenname
Disc Medicine Inc
Sektor
Branche
Telefon
(617) 674-9274
Adresse
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
74.78 | 2.86B | 0 | -241.60M | -201.34M | -6.6167 |
VRTX
Vertex Pharmaceuticals Inc
|
491.34 | 124.70B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
632.90 | 66.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
887.18 | 55.17B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
291.37 | 38.90B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
182.08 | 38.71B | 742.00K | -1.37B | -1.07B | -7.0731 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-03 | Fortgesetzt | Stifel | Buy |
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-06-11 | Fortgesetzt | Raymond James | Strong Buy |
| 2025-02-27 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-04-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-05-17 | Eingeleitet | Raymond James | Outperform |
| 2023-04-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Eingeleitet | Stifel | Buy |
| 2023-04-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-03-23 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-28 | Eingeleitet | SVB Securities | Outperform |
Alle ansehen
Disc Medicine Inc Aktie (IRON) Neueste Nachrichten
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Embecta Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EMBC - GlobeNewswire Inc.
Disc Medicine Investor News: If You Have Suffered Losses in - GlobeNewswire
(IRON) Risk Channels and Responsive Allocation - Stock Traders Daily
Form 144 Disc Medicine For: 26 June By Investing.com - Investing.com Nigeria
IRON Stock Climbs As Clinical Wins Offset Insider Selling - timothysykes.com
IRON (NASDAQ: IRON) notice: proposed 2,500-share option sale; prior 7,500-share 10b5-1 - Stock Titan
Disc Medicine, Inc. Actuals & Estimates (NASDAQ:IRON) - TradingView
Form 4 Disc Medicine Inc For: 24 June By Investing.com - Investing.com Australia
Disc Medicine, Inc. (IRON) 8-K Filing: Company Details, Nasdaq Listing, and Contact Info – June 2026 - Minichart
Disc Medicine COO Jonathan Yu sells $704,795 of iron common stock - Investing.com Nigeria
Disc Medicine (NASDAQ: IRON) COO exercises options, sells 9,700 shares under 10b5-1 plan - Stock Titan
Disc Medicine Stockholders Approve Governance and Executive Pay - TipRanks
Disc Medicine (NASDAQ: IRON) investors re-elect directors and ratify Ernst & Young - Stock Titan
Disc Medicine CLO Rahul Khara sells $526,660 in company stock By Investing.com - Investing.com South Africa
Disc Medicine CEO Quisel sells $2.38 million in company shares By Investing.com - Investing.com South Africa
Disc Medicine CLO Rahul Khara sells $526,660 in company stock - Investing.com UK
Form 4 Disc Medicine Inc For: 23 June By Investing.com - Investing.com Nigeria
Disc Medicine CEO Quisel sells $2.38 million in company shares - Investing.com
Disc Medicine Insider Sold Shares Worth $2,387,296, According to a Recent SEC Filing - marketscreener.com
Disc Medicine (NASDAQ: IRON) legal chief exercises options, sells 7,500 shares - Stock Titan
Disc Medicine (NASDAQ: IRON) CEO trades 34K shares under Rule 10b5-1 plan - Stock Titan
Disc Medicine (IRON) director receives 6,212 options vesting by 2027 - Stock Titan
Disc Medicine (IRON) grants director Liam Ratcliffe 6,212 stock options - Stock Titan
Disc Medicine (NASDAQ: IRON) director receives grant of 6,212 stock options - Stock Titan
Disc Medicine (NASDAQ: IRON) director granted 6,212 stock options at $70.79 strike - Stock Titan
Director at Disc Medicine (NASDAQ: IRON) granted 6,212 stock options at $70.79 - Stock Titan
Disc Medicine (NASDAQ: IRON) director Nadim Ahmed awarded 5,176 stock options - Stock Titan
Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns - Stocktwits
Jonathan Yu proposes sale of 10,000 IRON shares (NASDAQ: IRON) - Stock Titan
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), ... - Caledonian Record
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - PR Newswire
[144] Disc Medicine, Inc. SEC Filing - Stock Titan
Disc Medicine (NASDAQ: IRON) COO exercises options, sells 18,612 shares - Stock Titan
Finanzdaten der Disc Medicine Inc-Aktie (IRON)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):